Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Estrogen Receptor/ERR
    (4)
  • Estrogen/progestogen Receptor
    (3)
  • Anti-infection
    (1)
  • Antifection
    (1)
  • COX
    (1)
  • Phosphorylase
    (1)
  • Others
    (10)
Filter
Search Result
Results for "

antiestrogenic

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    17
    TargetMol | Inhibitors_Agonists
  • Natural Products
    5
    TargetMol | Natural_Products
22393-62-0_peak 2
T979622393-63-1In house
22393-62-0_peak 2 exhibits some aspects of the antiestrogenic activity and other actions that may be connected to the estrogenic properties. A mixture of the (Z)- and (E)-isomers (Broparestrol, INN) is used in dermatology.
  • Inquiry Price
Size
QTY
Chlorotrianisene
tris(p-methoxyphenyl)chloroethylene, tri-p-anisylchloroethylene, TACE, CTA
T2569569-57-3
Chlorotrianisene (tri-p-anisylchloroethylene) is an orally bioavailable, highly lipophilic, synthetic triphenylethylene (TPE) derivative and selective estrogen receptor modulator (SERM), with predominantly estrogenic but also antiestrogenic activities.
  • Inquiry Price
Size
QTY
Endoxifen (E-isomer)
Endoxifen E-isomer, E-Endoxifen
T11200114828-90-9
Endoxifen E-isomer (E-Endoxifen) is the E-isomer of (Z)-Endoxifen. Endoxifen E-isomer has antiestrogenic effects.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
FLTX1
T89841481401-71-1
FLTX1 is a fluorescent derivative of Tamoxifen, designed to efficiently target and label intracellular Tamoxifen-binding sites (estrogen receptors) both under permeabilized and non-permeabilized conditions. Additionally, FLTX1 demonstrates strong antiestrogenic activity in breast cancer cells, resembling the potent antiestrogenic properties of Tamoxifen. Notably, FLTX1 does not exhibit any estrogenic agonistic effect on the uterus.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
N-Desmethyltamoxifen
T12148L31750-48-8
N-Desmethyltamoxifen, the principal metabolite of tamoxifen in humans, serves as an efficacious modulator of ceramide metabolism within human AML cells by inhibiting ceramide glycosylation, hydrolysis, and sphingosine phosphorylation. Although it demonstrates weak antiestrogenic properties, it acts as a protein kinase C (PKC) inhibitor with a potency ten times greater than that of tamoxifen.
  • Inquiry Price
3-6 months
Size
QTY
OP-1074
T123121443752-76-8
OP-1074 is a pure antiestrogen and a selective degrader of ER, demonstrating specific antiestrogenic activity for ERα and ERβ.
  • Inquiry Price
6-8 weeks
Size
QTY
Zuclomiphene citrate
T134157619-53-6
Zuclomiphene citrate, a cis isomer of Clomiphene citrate, exhibits an antiestrogenic effect and inhibits the secretion of luteinizing hormone (LH) more effectively than its trans isomer.
  • Inquiry Price
6-8 weeks
Size
QTY
RU 45144
RU45144,RU-45144
T26154119286-92-9
RU 45144 is an estradiol derivative with antiestrogenic activity.
  • Inquiry Price
6-8 weeks
Size
QTY
LY 183648
LY-183648,LY183648
T27884102993-90-8
LY 183648 has antiestrogenic activity. LY117018 inhibited PAIII metastasis to the gluteal (97%) and iliac lymph nodes (88%).
  • Inquiry Price
6-8 weeks
Size
QTY
Tracheloside
T385533464-71-0
Tracheloside significantly decreases the activity of alkaline phosphatase (IC50: 0.31 μg ml), a level of inhibition comparable to that of tamoxifen (IC50: 0.43 μg ml).
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
Arzoxifene
LY353381,Arzoxifene,SERMIII
T39259182133-25-1
Arzoxifene (LY353381) is an orally active selective estrogen receptor modulator (SERM) with a fixed ring structure similar to raloxifene. It exhibits potent antiestrogenic effects on breast cancer and endometrium with minimal side effects and provides beneficial estrogenic effects on bone health and lipid profile.
  • Inquiry Price
Size
QTY
HIF-1α-IN-3
T611612170715-64-5
HIF-1α-IN-3, also known as Compound (S)-3f, is a hypoxia-selective inhibitor of HIF-1α. It exhibits potent antiestrogenic activity [1].
  • Inquiry Price
6-8 weeks
Size
QTY
TAS-108 citrate
T69696229634-98-4
TAS-108, also known as SR16234, is a synthetic, antiestrogenic steroidal compound with potential antitumor activity. TAS-108 binds to and inhibits estrogenic receptor alpha (ERa), mainly expressed in the mammary gland and uterus and upregulated in estrogen-dependent tumors. Blockage of ERa by TAS-108 prevents the binding and effects of estrogen and may lead to an inhibition of estrogen-dependent cancer cell proliferation. TAS-108 also is a partial agonist of the estrogenic receptor beta (ERb), expressed in many tissues including the central nervous system, urogenital tract, bone and cardiovascular system, thereby exerting a positive effect on these tissues.
  • Inquiry Price
6-8 weeks
Size
QTY
7-Hydroxyflavanone
T79996515-36-2
7-Hydroxyflavanone shows antimicrobial activity against Streptococcus pneumoniae clinical isolates.
  • Inquiry Price
Size
QTY
Millewanin G
TN4565874303-33-0
Millewanin G shows antiestrogenic activity.
  • Inquiry Price
Size
QTY
Millewanin H
TN4566874303-34-1
Millewanins H shows antiestrogenic activity.
  • Inquiry Price
Size
QTY
Pachyaximine A
TN4731128255-08-3
Pachyaximine A possesses significant antibacterial activity against Escherichia coli, Staphylococcus aureus, Corynebacterium diphtheriae and Corynebacterium pyrogenes. (-)-Pachyaximine A demonstrates significant activity as antiestrogen binding site (AEBS
  • Inquiry Price
Size
QTY